Background: Knowledge of clinical course in advanced jejunoileal neuroendocrine tumors (NETs) is poor. Aim: To investigate progression-free survival (PFS), overall survival (OS), and possible predictors for disease progression (DP) in advanced jejunoileal NETs. Patients and methods: We carried out a multicenter, retrospective analysis of incoming patients with sporadic advanced jejunoileal NETs. PFS and OS were assessed by Kaplan-Meier analysis. Risk factors for progression were analyzed by the Cox proportional hazards method. Results: Of the 114 patients enrolled, 46.5% had functioning tumors, 93.9% had stage IV disease, and 57.3 and 42.7% were G1 and G2 tumors, respectively. During a median follow-up of 48 months (interquartile range 29-84 months), DP occurred in 61.4% of patients, after 19 months (interquartile range 10-41 months) from diagnosis. Median PFS was 36 months. The 2-year and 5-year PFS were 59 and 33%, respectively, while 5-year OS was 77.5%. Ki67 was the sole strong independent risk factor for unfavorable outcome according to multivariate analysis, being significantly associated with both PFS and OS. Conclusions: DP occurred in the majority of patients with advanced jejunoileal NETs, with median PFS being 36 months. Ki67 was a significant predictor of DP and should be considered in determining appropriate treatments and planning follow-up for these patients.

Risk Factors for Disease Progression in Advanced Jejunoileal Neuroendocrine Tumors / Panzuto, F; Campana, D; Fazio, N; Brizzi, Mp; Boninsegna, L; Nori, F; Di Meglio, G; Capurso, G; Scarpa, A; Dogliotti, L; De Braud, F; Tomassetti, P; DELLE FAVE, Gianfranco; Falconi, M.. - In: NEUROENDOCRINOLOGY. - ISSN 1423-0194. - 96:1(2012), pp. 32-40. [10.1159/000334038]

Risk Factors for Disease Progression in Advanced Jejunoileal Neuroendocrine Tumors

Panzuto F;DELLE FAVE, Gianfranco
;
2012

Abstract

Background: Knowledge of clinical course in advanced jejunoileal neuroendocrine tumors (NETs) is poor. Aim: To investigate progression-free survival (PFS), overall survival (OS), and possible predictors for disease progression (DP) in advanced jejunoileal NETs. Patients and methods: We carried out a multicenter, retrospective analysis of incoming patients with sporadic advanced jejunoileal NETs. PFS and OS were assessed by Kaplan-Meier analysis. Risk factors for progression were analyzed by the Cox proportional hazards method. Results: Of the 114 patients enrolled, 46.5% had functioning tumors, 93.9% had stage IV disease, and 57.3 and 42.7% were G1 and G2 tumors, respectively. During a median follow-up of 48 months (interquartile range 29-84 months), DP occurred in 61.4% of patients, after 19 months (interquartile range 10-41 months) from diagnosis. Median PFS was 36 months. The 2-year and 5-year PFS were 59 and 33%, respectively, while 5-year OS was 77.5%. Ki67 was the sole strong independent risk factor for unfavorable outcome according to multivariate analysis, being significantly associated with both PFS and OS. Conclusions: DP occurred in the majority of patients with advanced jejunoileal NETs, with median PFS being 36 months. Ki67 was a significant predictor of DP and should be considered in determining appropriate treatments and planning follow-up for these patients.
2012
neuroendocrine tumors; progression; Ki67
01 Pubblicazione su rivista::01a Articolo in rivista
Risk Factors for Disease Progression in Advanced Jejunoileal Neuroendocrine Tumors / Panzuto, F; Campana, D; Fazio, N; Brizzi, Mp; Boninsegna, L; Nori, F; Di Meglio, G; Capurso, G; Scarpa, A; Dogliotti, L; De Braud, F; Tomassetti, P; DELLE FAVE, Gianfranco; Falconi, M.. - In: NEUROENDOCRINOLOGY. - ISSN 1423-0194. - 96:1(2012), pp. 32-40. [10.1159/000334038]
File allegati a questo prodotto
File Dimensione Formato  
Panzuto_RiskFactors-forDisease-Progression_2012.pdf

solo gestori archivio

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 688.91 kB
Formato Adobe PDF
688.91 kB Adobe PDF   Contatta l'autore

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/436918
Citazioni
  • ???jsp.display-item.citation.pmc??? 14
  • Scopus 49
  • ???jsp.display-item.citation.isi??? 47
social impact